Drunk driving is responsible for about 1 in 3 traffic fatalities in the United States, according to data ValuePenguin analyzed from the National Highway Traffic Safety Administration (NHTSA). The ...
ImmuneOnco announced dosing of first patient in its recently initiated Phase 1b/2 clinical trial of IMM2510/SYN-2510 in combination with chemotherapy in patients with advanced NSCLC in China ...
The biggest stories of the day delivered to your inbox.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback